Compare IBOC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IBOC | TFX |
|---|---|---|
| Founded | 1966 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.6B |
| IPO Year | 1995 | 1994 |
| Metric | IBOC | TFX |
|---|---|---|
| Price | $72.25 | $132.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $87.00 | ★ $138.75 |
| AVG Volume (30 Days) | 352.9K | ★ 754.4K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.02% | 1.03% |
| EPS Growth | ★ 0.76 | N/A |
| EPS | ★ 6.62 | N/A |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $58.26 | $100.18 |
| 52 Week High | $75.44 | $138.93 |
| Indicator | IBOC | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 75.05 |
| Support Level | $67.24 | $102.20 |
| Resistance Level | $72.62 | $136.46 |
| Average True Range (ATR) | 1.30 | 3.82 |
| MACD | 0.38 | 1.59 |
| Stochastic Oscillator | 88.29 | 87.07 |
International Bancshares Corp is a registered multibank financial holding company providing a diversified range of commercial and retail banking services in its main banking and branch facilities located in north, south, central, and southeast Texas and the State of Oklahoma.. The company provides commercial and retail banking services in Texas and Oklahoma. The services provided by the bank include checking, savings, bank cards, lending, insurance, mortgage, investments, and other services.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.